Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment?

Eur Heart J. 2005 Aug;26(16):1685; author reply 1685-6. doi: 10.1093/eurheartj/ehi363. Epub 2005 Jun 15.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antigens, CD34 / metabolism*
  • Bone Marrow Cells / physiology*
  • Cell Movement / physiology
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Myocardial Infarction / pathology*
  • Stem Cells / cytology
  • Ventricular Dysfunction, Left / pathology

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antigens, CD34
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors